A detailed history of Bayesian Capital Management, LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 22,900 shares of SRRK stock, worth $848,903. This represents 0.13% of its overall portfolio holdings.

Number of Shares
22,900
Holding current value
$848,903
% of portfolio
0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.07 - $45.73 $161,903 - $1.05 Million
22,900 New
22,900 $989,000
Q1 2024

May 15, 2024

BUY
$13.2 - $17.76 $191,400 - $257,520
14,500 New
14,500 $257,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.91B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.